Citigroup To $47? Plus This Analysts Predicts $95 For Papa John’s

Goldman Sachs cut Citigroup Inc. (NYSE: C) price target from $54 to $47. Citigroup shares fell 0.4% to $41.51 in pre-market trading.
  • Goldman Sachs cut Citigroup Inc. (NYSE:C) price target from $54 to $47. Citigroup shares fell 0.4% to $41.51 in pre-market trading.
  • RBC Capital cut The Mosaic Company (NYSE:MOS) price target from $85 to $65. Mosaic shares fell 1% to $47.85 in pre-market trading.
  • Morgan Stanley boosted Box, Inc. (NYSE:BOX) price target from $32 to $34. Box shares rose 3.7% to $25.29 in pre-market trading.
  • Mizuho lowered the price target on ALLETE, Inc. (NYSE:ALE) from $58 to $50. ALLETE shares fell 2.3% to close at $50.05 on Friday.
  • Wells Fargo cut price target for Keurig Dr Pepper Inc. (NASDAQ:KDP) from $43 to $41. Keurig Dr Pepper shares fell 0.3% to $35.71 in pre-market trading.
  • RBC Capital raised the price target on New Gold Inc. (NYSE:NGD) from $1 to $1.25. New Gold shares rose 3% to close at $0.88 on Friday.
  • Wedbush cut the price target for Papa John’s International, Inc. (NASDAQ:PZZA) from $109 to $95. Papa John’s fell 2.4% to close at $70.01 on Friday.
  • Chardan Capital boosted the price target on Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) from $62 to $65. Rocket Pharmaceuticals rose 1.8% to $16.25 in pre-market trading.
  • Keybanc reduced the price target on Crown Castle Inc. (NYSE:CCI) from $205 to $177. Crown Castle shares rose 0.2% to close at $144.55 on Friday.
  • SVB Leerink cut the price target on Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) from $21 to $17. Intercept Pharmaceuticals shares fell 15% to close at $13.95 on Monday.

Don’t forget to check out our premarket coverage here .

Check out this: Investor Fear Eases Slightly Despite Dow Dipping Around 9% In September

Total
0
Shares
Related Posts
Read More

5 On-The-Money Stock Picks From Benzinga’s Most Accurate Analysts

Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes to one single stock, analyst ratings and price targets can vary widely, leaving investors confused about which analyst's opinion to trust.

CHRA